MedTrace Logo

Meaning-Centered Psychotherapy in Advanced Cancer

NCT00067288 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2006-08-18

No results posted yet for this study

Summary

We have developed an 8-week Meaning-Centered Group Psychotherapy designed to help patients with advanced cancer sustain or enhance a sense of meaning, peace and purpose despite the limitations of their cancer illness. This project's overall aim is to explore the feasibility and efficacy of this new and unique psychotherapy intervention for advanced cancer patients in enhancing psychological and spiritual well-being and quality of life by comparing it with a standard supportive group psychotherapy.

Conditions

  • Lymphoma, Non-Hodgkin
  • Neoplasms

Interventions

BEHAVIORAL

Meaning-Centered Group Psychotherapy

BEHAVIORAL

Standard Supportive Group Psychotherapy

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    lead NIH

Principal Investigators

  • William Breitbart, MD · Memorial Sloan Kettering Cancer Center

  • Christopher Gibson, PhD · Project Coordinator Memorial Sloan-Kettering Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
ECT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-05-31
Completion
2006-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00067288 on ClinicalTrials.gov